METTL14, a favorable factor for ccRCC patients’ prognosis, facilitated m6A modification on ITGB4 3′UTR and subsequently accelerated ITGB4 mRNA degradation, leading to its declined expression. The gene discussed is ITGB4; the disease is nonpapillary renal cell carcinoma.